PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Pronged immune drug joins fight against tough ovarian cancers
Disease control Not yet recruitingThis study is testing if adding a new immune-boosting drug (called a bispecific antibody) to standard chemotherapy before surgery helps patients with advanced ovarian cancer. The goal is to shrink tumors more effectively so surgeons can remove all visible cancer during a later op…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Three-Drug attack on tough ovarian cancers
Disease control Not yet recruitingThis study is testing whether a combination of three drugs—benmelstobart, anlotinib, and cyclophosphamide—can help control recurrent ovarian, fallopian tube, or primary peritoneal cancer. It will enroll 40 participants in China who have seen their cancer return after previous tre…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC